1. Home
  2. BHVN vs CTRE Comparison

BHVN vs CTRE Comparison

Compare BHVN & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CTRE
  • Stock Information
  • Founded
  • BHVN 2013
  • CTRE 2013
  • Country
  • BHVN United States
  • CTRE United States
  • Employees
  • BHVN N/A
  • CTRE N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CTRE Real Estate Investment Trusts
  • Sector
  • BHVN Health Care
  • CTRE Real Estate
  • Exchange
  • BHVN Nasdaq
  • CTRE Nasdaq
  • Market Cap
  • BHVN 4.2B
  • CTRE 5.0B
  • IPO Year
  • BHVN 2017
  • CTRE N/A
  • Fundamental
  • Price
  • BHVN $36.85
  • CTRE $24.93
  • Analyst Decision
  • BHVN Strong Buy
  • CTRE Hold
  • Analyst Count
  • BHVN 14
  • CTRE 6
  • Target Price
  • BHVN $63.15
  • CTRE $30.83
  • AVG Volume (30 Days)
  • BHVN 752.7K
  • CTRE 1.9M
  • Earning Date
  • BHVN 03-03-2025
  • CTRE 02-12-2025
  • Dividend Yield
  • BHVN N/A
  • CTRE 4.65%
  • EPS Growth
  • BHVN N/A
  • CTRE 60.00
  • EPS
  • BHVN N/A
  • CTRE 0.80
  • Revenue
  • BHVN N/A
  • CTRE $296,286,000.00
  • Revenue This Year
  • BHVN N/A
  • CTRE N/A
  • Revenue Next Year
  • BHVN $154.39
  • CTRE $21.63
  • P/E Ratio
  • BHVN N/A
  • CTRE $31.16
  • Revenue Growth
  • BHVN N/A
  • CTRE 36.05
  • 52 Week Low
  • BHVN $26.80
  • CTRE $22.46
  • 52 Week High
  • BHVN $62.21
  • CTRE $33.15
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 40.96
  • CTRE 34.74
  • Support Level
  • BHVN $38.40
  • CTRE $25.26
  • Resistance Level
  • BHVN $42.82
  • CTRE $26.75
  • Average True Range (ATR)
  • BHVN 2.14
  • CTRE 0.66
  • MACD
  • BHVN -0.16
  • CTRE -0.07
  • Stochastic Oscillator
  • BHVN 0.34
  • CTRE 6.60

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The Company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements. The Company generate revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property (including property taxes, insurance, maintenance and repair costs and capital expenditures).

Share on Social Networks: